Top Markets
Coin of the day
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.

Jafron Biomedical Co.,Ltd.

300529
Rank in Stocks #6731
Jafron Biomedical Co.,Ltd. engages in the research and development, production,... Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Share Price
$2.37
Last synced: 2026-08-12
Market Cap
$1.89B
Change (1 day)
-0.24%
Change (1 year)
-28.81%
Country
CN
Trade Jafron Biomedical Co.,Ltd. (300529)

Category

P/B ratio for Jafron Biomedical Co.,Ltd. (300529)
P/B ratio as of 2026 TTM: 0
According to Jafron Biomedical Co.,Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Jafron Biomedical Co.,Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors